Process Measures Sample Clauses

Process Measures. 1. One hundred percent (100%) of all admissions to the PHF shall include the proper submission of noticing forms to DBH. 2. 100% of the dates for which Day Treatment Intensive (DTI) is provided shall be authorized by the DBH Access Unit

Process Measures. ‌ ACCMP selects at least three (3) from the following six (6) process measures annually: 1. IOG meeting attendance Measure: all partners signing MOU attending 75% of the time at 75% of the meetings. Sign-in sheets and meeting minutes will confirm attendance. 2. Family agency or member participation on the IOG as a voting member Measure: a voting family member or agency will be in attendance at 50% of all IOG meetings held within the fiscal year. Sign-in sheets and meeting minutes will confirm attendance. 3. Seventy-five (75%) percent of the agencies contribute resources at a service level, either in-kind or actual funds Measure: as determined in section V “Funding Sources” table of the annual MOU. 4. Use of Evidence-Based or Evidence-Informed practices Measure: at least one (1) evidence-based, or evidence-informed practice will be implemented/used under the IOG, as reflected in the current approved MOU. 5. Process of Continuous Quality Improvement used by the IOG Measure: IOG meeting minutes will reflect the continuous quality improvement practices used to inform and improve efforts, at least one (1) time per year. 6. Evidence of cost-sharing will be reflected in the expenditures section of the annual report Measure: cost-sharing will be reflected in the expenditures section of the annual report.‌

Process Measures. 7.4.1.1 Increase percentage of enrollees who receive PCP annual visit; 7.4.1.2 Increase percentage of enrollees receiving initial and follow-up screenings; 7.4.1.3 Increase the number of enrollees who are contacted; 7.4.1.4 Increase the number of contacted enrollees with Integrated Care Plans (ICP); and 7.4.1.5 Increase percent of enrollees receiving Integrated Health Management (IHM) resources;

Process Measures. FRC will meet or exceed its membership recruitment and retention goals each year (defined by program in program design, item I).

Process Measures. All sessions after enrollment may be recorded to audio and video, including introductory, integrative and experimental sessions for research and training purposes. These recordings will be used for further development of the manual of standard procedures for performing MDMA-assisted psychotherapy in people with PTSD. Adherence criteria and competence ratings will be conducted by qualified, trained blinded adherence raters who will analyze video data from selected preparatory, experimental and integrative sessions. The elements included in adherence criteria are specific to each type of session. These ratings will be collected, at minimum, for each therapist team in the study. The goal of these ratings will be to correlate therapist adherence to the treatment manual with outcome as a part of the sponsor’s ongoing efforts to standardize treatment methods of MDMA-assisted psychotherapy for PTSD. The SOCQ is a 100-item questionnaire based on the “Peak Experience Profile” designed by ▇▇▇▇▇▇ and colleagues [166, 167]. Subjects respond to the SOCQ using a six-point Likert-type scale anchored at 0=none at all and 5=extreme (more than ever before in my life). It has seven subscale scores; internal unity, external unity, transcendence of time and space, ineffability and paradoxicality (claim of difficulty in describing the experience in words), sense of sacredness, noetic quality, and deeply felt positive mood. The measure is a self-report instrument and takes approximately 20 to 30 minutes to complete. Subjects will complete the SOCQ after each experimental session, at any time between the end of an experimental session and prior to leaving the treatment facility the next day. Response to study participation and perceived degree of choice in taking part in the study will be assessed with the Reactions to Research Participation Questionnaire (RRPQ) [168]. Subjects will complete this measure during their final study visit, roughly six weeks after the last experimental session. The RRPQ is intended to assess the subject’s experience as a research subject, perceived reasons for consenting to be a research subject and perceived freedom to take part in the study, and is a process measure. Questions regarding the belief of condition assignment and certainty of the belief will be asked of the therapists and subjects at the integrative session on the day after each blinded experimental session in Stage 1. Each therapist responsible for treating the subject will indicate the...

Process Measures. Please select all the process measures that the CMP site will attempt to achieve. Each CMP site must select at least three (3). X IOG meeting attendance (all partners signing MOU attending 75% of the time at 75% of scheduled meetings); X Family agency or member participation on the IOG as a voting member; X Seventy-five (75%) percent of the agencies contribute resources at a service level, either in-kind or actual funds; X Use of Evidence Based or Evidence Informed practices; X Process of Continuous Quality Improvement used by the IOG; X Evidence of cost-sharing X Cost acquired by organizations within the MOU to serve a child, youth, and/or family when the items are tangible will be logged into the data information system.

Process Measures. Please select all the process measures that the CMP site will attempt to achieve. Each CMP site must select at least three (3). X IOG meeting attendance (all partners signing MOU attending 75% of the time at 75% of scheduled meetings); X Family agency or member participation on the IOG as a voting member; X Seventy-five (75%) percent of the agencies contribute resources at a service level, either in-kind or actual funds; X Use of Evidence Based or Evidence Informed practices; X Process of Continuous Quality Improvement used by the IOG; X Evidence of cost-sharing ☐ Sharing costs of resources, programs, and/or services will be tracked through a spreadsheet that identifies the need of the family, the cost, other agencies’ contributions as applicable, and Routt County IOG’s contribution as applicable. Cost sharing through

Process Measures. All psychotherapy sessions, including experimental sessions, will be recorded to audio and video, with all recordings preserved for research and training purposes. Adherence criteria and competence ratings will be conducted by qualified, trained blinded adherence raters who will analyze video data from selected preparatory, experimental and integrative sessions. The elements included in adherence criteria are specific to each type of session. These ratings will be collected, at minimum, for each therapist team in the study. The goal of these ratings will be to correlate therapist adherence to the treatment manual with outcome as a part of the sponsor’s ongoing efforts to standardize treatment methods of MDMA-assisted psychotherapy for PTSD. Therapeutic alliance will be assessed using the Segmented Working Alliance Inventory- Observer form (S-WAI-O) on video data from selected preparatory, experimental and integrative sessions [114]. The S-WAI-O is an observer-based measure designed to assess changes in working alliance over the course of a session. The scale can provide two scores, one measuring the bond between the subject and therapist and the other measuring their agreement on tasks of therapy. These ratings will be collected, at minimum, for each therapist team in the study. The goal of these ratings will be to correlate overall S-WAI-O scores of therapeutic alliance with outcome, as measured by CAPS scores. Belief of condition assignment and certainty will be collected from each therapist responsible for treating the subject and the subject at the integrative session on the day after each blinded experimental session in Stage 1. At the primary endpoint, the IR for the study will also provide their guess and certainty of condition assignment prior to unblinding. These beliefs are collected as a part of the sponsor’s ongoing initiative to optimize the double-blind as a part of dose response studies.

Process Measures. 1. Bayaud agrees to meet all state metrics as required for the Colorado Works/TANF program. Bayaud will be responsible for their proportionate share cases assigned to their organizations. Bayaud will be responsible for demonstrating their performance and compliance in the following areas: a. Initial Engagement (80% of families are engaged in Individual Plans developed by the contractor and associated activities that support the assessment within 30 days of referral) b. Hours of participation are entered timely and accurately into the Colorado Benefits Management System (CBMS) and cases included in Denver’s share of Colorado’s federal sample are given priority for review and revision, as per direction from the Colorado Department of Human Services (CDHS) c. Ongoing Engagement Rate (Work Participation) (40% of all-families are in a countable core and/or non-core work activity with verified hours of participation each month 2. ▇▇▇▇▇▇ will report monthly or as requested by the Denver Welfare Reform Board on its progress in moving Denver TANF participants to SSI/SSDI. The report should be accompanied with a narrative that speaks to the progress made with meeting performance goals and strategies that identify specific measures that will be taken to assist in meeting the performance goal. Report shall include information on: a. Number of Denver TANF participants enrolled in ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 1. Number of Denver TANF participants screened for SSI/SSDI acquisition 2. Number of Denver TANF participants approved for SSI/SSDI on initial decision 3. Number of Denver TANF participants denied SSI/SSDI and forwarded to disability lawyer for appeal